233 related articles for article (PubMed ID: 26101867)
1. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
Enomoto H; Nakamura H; Liu W; Nishiguchi S
Int J Mol Sci; 2015 Jun; 16(6):14086-97. PubMed ID: 26101867
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
6. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Cell Physiol Biochem; 2009; 24(3-4):253-62. PubMed ID: 19710540
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
9. Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).
Yamamoto T; Nakamura H; Liu W; Cao K; Yoshikawa S; Enomoto H; Iwata Y; Koh N; Saito M; Imanishi H; Shimomura S; Iijima H; Hada T; Nishiguchi S
J Gastroenterol; 2009; 44(3):228-35. PubMed ID: 19214667
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatoma-derived growth factor in hepatocarcinogenesis.
Yoshida K; Nakamura H; Okuda Y; Enomoto H; Kishima Y; Uyama H; Ito H; Hirasawa T; Inagaki S; Kawase I
J Gastroenterol Hepatol; 2003 Nov; 18(11):1293-301. PubMed ID: 14535987
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Zhou Y; Zhou N; Fang W; Huo J
Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397
[TBL] [Abstract][Full Text] [Related]
12. HDGF-related protein-2 (HRP-2) acts as an oncogene to promote cell growth in hepatocellular carcinoma.
Gao K; Xu C; Jin X; Wumaier R; Ma J; Peng J; Wang Y; Tang Y; Yu L; Zhang P
Biochem Biophys Res Commun; 2015 Mar; 458(4):849-55. PubMed ID: 25689719
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies.
Enomoto H; Nakamura H; Nishikawa H; Nishiguchi S; Iijima H
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545762
[TBL] [Abstract][Full Text] [Related]
14. Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells.
Enomoto H; Nishimura T; Fukunushi S; Shiomi H; Iijima H
In Vivo; 2023; 37(5):1975-1979. PubMed ID: 37652516
[TBL] [Abstract][Full Text] [Related]
15. HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.
Xiao Q; Qu K; Wang C; Kong Y; Liu C; Jiang D; Saiyin H; Jia F; Ni C; Chen T; Zhang Y; Zhang P; Qin W; Sun Q; Wang H; Yi Q; Liu J; Huang H; Yu L
Gut; 2013 Mar; 62(3):440-51. PubMed ID: 22490522
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
19. HRP-3 protects the hepatoma cells from glucose deprivation-induced apoptosis.
Cai H; Jiang D; Qi F; Xu J; Yu L; Xiao Q
Int J Clin Exp Pathol; 2015; 8(11):14383-91. PubMed ID: 26823754
[TBL] [Abstract][Full Text] [Related]
20. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
